BriaCell Therapeutics (BCTX) Institutional Ownership $0.79 -0.02 (-2.46%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for BriaCell Therapeutics (NASDAQ:BCTX)CurrentInstitutional OwnershipPercentage15.42%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$620.86KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.47M Get BCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling BriaCell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BCTX Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here BriaCell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/16/2024 Vontobel Holding Ltd.80,000$99K0.0%N/A0.438% 4/29/2024Onyx Bridge Wealth Group LLC50,000$143K0.0%+66.7%0.313% 4/27/2024 K.J. Harrison & Partners Inc87,044$249K0.0%+7.8%0.545% 2/14/2024Wasatch Advisors LP267,410$1.56M0.0%-48.0%1.673% 2/12/2024Redmond Asset Management LLC133,569$781K0.3%-3.1%0.836% 2/6/2024National Bank of Canada FI7,500$40K0.0%+200.0%0.047% Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/2/2024 K.J. Harrison & Partners Inc80,715$476K0.1%+22.1%0.505% 1/31/2024Onyx Bridge Wealth Group LLC30,000$176K0.0%N/A0.188% 11/13/2023K2 Principal Fund L.P.24,969$156K0.0%N/A0.156% 10/31/2023 K.J. Harrison & Partners Inc66,090$411K0.1%+90.8%0.414% 10/25/2023 Concord Wealth Partners10,775$67K0.0%-29.5%0.067% 8/11/2023Natixis90,250$579K0.0%N/A0.565% 8/8/2023Wasatch Advisors LP612,088$3.93M0.0%-0.6%3.830% 8/8/2023 Concord Wealth Partners15,275$98K0.0%-14.1%0.096% 8/2/2023Bank of Montreal Can34,629$217K0.0%N/A0.217% 7/21/2023 K.J. Harrison & Partners Inc34,640$217K0.0%-67.3%0.217% 4/25/2023 K.J. Harrison & Partners Inc105,933$785K0.2%-75.2%0.683% 2/7/2023Lynwood Capital Management Inc.1,530,000$6.69M8.0%+27.7%9.860% 1/25/2023 K.J. Harrison & Partners Inc427,583$2.52B0.5%-10.9%2.755% 11/8/2022Apollon Wealth Management LLC17,900$101K0.0%+12.6%0.115% 11/7/2022Virtu Financial LLC48,347$272K0.0%+362.5%0.312% 10/25/2022Lynwood Capital Management Inc.1,198,000$6.73M7.4%+94.8%7.720% 10/21/2022 K.J. Harrison & Partners Inc479,838$2.75M1.0%-70.1%3.092% 8/11/2022Apollon Wealth Management LLC15,900$92K0.0%+14.4%0.102% 8/2/2022Lynwood Capital Management Inc.615,000$3.55M4.0%-18.0%3.963% 7/27/2022 K.J. Harrison & Partners Inc1,607,027$9.19M2.5%+18.9%10.355% 5/5/2022Lynwood Capital Management Inc.750,000$7.61M8.2%-4.5%4.908% 4/21/2022 K.J. Harrison & Partners Inc1,351,782$13.75M2.2%N/A8.847% 4/20/2022 Concord Wealth Partners16,775$170K0.0%+31.3%0.110% 2/9/2022 Insight Advisors LLC PA16,900$140K0.0%N/A0.106% 2/3/2022 Total Clarity Wealth Management Inc.15,818$131K0.1%+38.5%0.099% 1/21/2022 Concord Wealth Partners12,775$106K0.0%N/A0.080% 11/16/2021Two Sigma Investments LP62,139$503K0.0%N/A0.404% 11/16/2021Voloridge Investment Management LLC156,946$1.27M0.0%N/A1.021% 10/22/2021Redmond Asset Management LLC136,593$1.11M0.3%+3.7%0.890% 10/21/2021 Total Clarity Wealth Management Inc.11,425$93K0.0%N/A0.074% 10/19/2021 Belvedere Trading LLC13,608$107K0.0%N/A0.089% 10/13/2021FNY Investment Advisers LLC4,687$37K0.0%N/A0.031% 10/13/2021Gofen & Glossberg LLC IL10,000$81K0.0%N/A0.065% 8/25/2021Marshall Wace LLP63,226$337K0.0%N/A0.414% 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here8/17/2021Armistice Capital LLC570,343$3.04M0.1%N/A3.735% 8/16/2021Sabby Management LLC196,033$1.05M0.1%+22.4%1.284% 8/16/2021Marshall Wace LLP63,226$337K0.0%N/A0.414% 8/13/2021Altium Capital Management LP800,295$4.27M1.0%N/A5.241% 8/13/2021Murchinson Ltd.250,000$1.33M0.5%N/A1.637% 8/12/2021MMCAP International Inc. SPC400,000$2.13M0.1%N/A2.620% 8/12/2021Kepos Capital LP500,000$2.67M0.2%N/A3.274% 8/12/2021Eqis Capital Management Inc.21,182$113K0.0%+29.6%0.139% 8/11/2021CVI Holdings LLC320,800$1.71M0.1%N/A2.101% 5/19/2021Virtu Financial LLC15,121$58K0.0%N/A0.260% 5/14/2021Eqis Capital Management Inc.16,339$63K0.0%N/A0.281% 5/6/2021Redmond Asset Management LLC131,731$508K0.2%N/A2.266% (Data available from 1/1/2016 forward) BCTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCTX shares? During the previous two years, 13 institutional investors and hedge funds held shares of BriaCell Therapeutics. The most heavily invested institutionals were Lynwood Capital Management Inc. ($6.69M), Wasatch Advisors LP ($1.56M), Redmond Asset Management LLC ($781K), Natixis ($579K), Virtu Financial LLC ($272K), K.J. Harrison & Partners Inc ($249K), and Bank of Montreal Can ($217K).Learn more on BCTX's institutional investors. What percentage of BriaCell Therapeutics stock is owned by institutional investors? 15.42% of BriaCell Therapeutics stock is owned by institutional investors. Learn more on BCTX's institutional investor holdings. Which institutional investors have been buying BriaCell Therapeutics stock? Of the 10 institutional investors that purchased BriaCell Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Lynwood Capital Management Inc. ($332K), Natixis ($90.25K), Vontobel Holding Ltd. ($80K), K.J. Harrison & Partners Inc ($52.40K), Onyx Bridge Wealth Group LLC ($50K), Virtu Financial LLC ($37.89K), and Bank of Montreal Can ($34.63K). How much institutional buying is happening at BriaCell Therapeutics? Institutional investors have bought a total of 709,146 shares in the last 24 months. This purchase volume represents approximately $3.29M in transactions. Which BriaCell Therapeutics major shareholders have been selling company stock? The following institutional investors have sold BriaCell Therapeutics stock in the last 24 months: K.J. Harrison & Partners Inc ($445.20K), Wasatch Advisors LP ($250.34K), Concord Wealth Partners ($7K), and Redmond Asset Management LLC ($4.27K). How much institutional selling is happening at BriaCell Therapeutics? Institutional investors have sold a total of 706,809 shares in the last 24 months. This volume of shares sold represents approximately $4.62M in transactions. Related Companies RPHM Major Shareholders KRON Major Shareholders IMRX Major Shareholders BRNS Major Shareholders THTX Major Shareholders ATNM Major Shareholders KZR Major Shareholders SCYX Major Shareholders ANEB Major Shareholders AADI Major Shareholders This page (NASDAQ:BCTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
